Comparative Effectiveness of Long-Acting Beta2-Agonist Combined with a Long-Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive Pulmonary Disease-Reference-Cited by-同舟云学术

Comparative Effectiveness of Long-Acting Beta2-Agonist Combined with a Long-Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive Pulmonary Disease

Published:2017-04 Issue:4 Volume:37 Page:447-455
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Samp Jennifer C.¹,Joo Min J.¹²³,Schumock Glen T.¹²,Calip Gregory S.¹²,Pickard A. Simon¹²,Lee Todd A.¹²

Affiliation:

1. Department of Pharmacy Systems, Outcomes and Policy; University of Illinois at Chicago; Chicago Illinois

2. Center for Pharmacoepidemiology and Pharmacoeconomic Research; University of Illinois at Chicago; Chicago Illinois

3. Division of Pulmonary, Critical Care, Sleep and Allergy Medicine, Department of Medicine; University of Illinois at Chicago; Chicago Illinois

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/phar.1913/fullpdf

Reference31 articles.

1. Differential pharmacology and clinical utility of emerging combination treatments in the management of COPD-role of umeclidinium/vilanterol;Malerba;Int J Chron Obstruct Pulmon Dis,2014

2. Total and state-specific medical and absenteeism costs of COPD among adults aged ≥ 18 years in the United States for 2010 and projections through 2020;Ford;Chest,2015

3. Global Strategy for Diagnosis, Management, and Prevention of COPD 2016 http://www.goldcopd.org/

4. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society;Qaseem;Ann Intern Med,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone–Salmeterol to Treat Chronic Obstructive Pulmonary Disease;Annals of Internal Medicine;2023-08

2. Chronic Obstructive Pulmonary Disease Exacerbations and Pneumonia Hospitalizations Among New Users of Combination Maintenance Inhalers;JAMA Internal Medicine;2023-07-01

3. Prescription Patterns of New Use of Fixed-Dose Combination Inhalers in Patients with Chronic Obstructive Pulmonary Disease: Long-Acting β2 Agonists Plus Long-Acting Muscarinic Antagonists versus Long-Acting β2 Agonists Plus Inhaled Corticosteroids;International Journal of Chronic Obstructive Pulmonary Disease;2023-04

4. Magnolia officinalis L. bark extract and respiratory diseases: From traditional Chinese medicine to western medicine via network target;Phytotherapy Research;2023-03-06

5. Evaluating a Cox marginal structural model to assess the comparative effectiveness of inhaled corticosteroids versus no inhaled corticosteroid treatment in chronic obstructive pulmonary disease;Annals of Epidemiology;2022-03